FIGURE

Fig. 5

ID

ZDB-FIG-230704-5

Publication

McKeown et al., 2022 - Pilot Study of Jadomycin B Pharmacokinetics and Anti-Tumoral Effects in Zebrafish Larvae and Mouse Breast Cancer Xenograft Models

Other Figures

All Figure Page

Back to All Figure Page

Fig. 5

Jadomycin B did not cause significant toxicity in female Balb/C mice with 4T1 tumors. Adult female Balb/C mice were injected with 100 000 4T1 cells into the fourth mammary fat pad on day 0, followed by jadomycin B (Jad B) treatment (12 mg/kg every 12 h) from day 6 to 15 after tumor cell implantation. Beginning on day 6, mouse weights were measured every 2 days (A). At the study endpoint, serum was collected and analyzed for alanine amino transferase (B) and creatinine (C) levels as markers of hepatic and renal toxicity, respectively. The data are shown as mean � SEM (n = 8). ^***P ? 0.001, compared to day 6, as determined by a two-way repeated measures ANOVA, with Bonferroni multiple comparison text (A). There were no significant differences in serum ALT (B) or creatinine (C) between groups, unpaired t-test.

Expression Data

Expression Detail

Antibody Labeling

Phenotype Data

Phenotype Detail

Acknowledgments

This image is the copyrighted work of the attributed author or publisher, and ZFIN has permission only to display this image to its users. Additional permissions should be obtained from the applicable author or publisher of the image. Full text @ Can. J. Physiol. Pharmacol.